Evotec SE EVO 深 滬
已收盤 05-08 16:00:00 美东时间
3.07
+0.020
+0.66%
華盛通- 最 高3.09
- 今 開3.08
- 成交量 4.56万股
- 最 低 3.03
- 昨 收 3.05
- 總市值 10.90亿
- 52周最高 4.80
- 市盈率 靜 --
- 換手率 0.01%
- 52周最低 2.308
- 委 比 47.90%
- 總股本 3.55亿
- 歷史最高 25.29
- 量 比 0.64
- 振 幅 1.97%
- 歷史最低 2.308
- 每 手 1
- 風險率 0.52%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Earnings Scheduled For May 6, 2026
Companies Reporting Before The Bell • Deluxe (NYSE:DLX) is expected to report q...
05-07 05:03
Evotec Raises FY2026 Sales Guidance from $814.906M-$908.038M to $819.700M-$913.380M vs $870.860M Est
Evotec (NASDAQ:EVO) raises FY2026 sales outlook from $814.906 million-$908.038 million to $819.700 million-$913.380 million vs $870.860 million estimate.
05-06 15:32
Evotec Q1 EPS $(0.40) Misses $0.08 Estimate, Sales $183.430M Miss $197.190M Estimate
Evotec (NASDAQ:EVO) reported quarterly losses of $(0.40) per share which missed the analyst consensus estimate of $0.08 by 600 percent. This is a 344.44 percent decrease over losses of $(0.10) per share from the same
05-06 15:30
Evotec Nominates Preclinical Development Candidate From Almirall Collaboration Targeting Immune-Mediated Inflammatory Skin Diseases
Joint Evotec-Almirall team advances small molecule program to preclinical development significantly outperforming standard industry timelinesCollaboration leverages Evotec's end-to-end integrated AI/ML-driven R&D
05-04 13:54
Boyd Gaming Posts Downbeat Q1 Results, Joins Coursera, Evotec And Other Big Stocks Moving Lower In Friday's Pre-Market Session
U.S. stock futures mixed, Dow down 100 points. Boyd Gaming Corp shares drop 6.1% after worse-than-expected Q1 results and $500M buyback plan.
04-24 20:03
电话会总结 ｜ Evotec(EVO)2025财年Q3业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Evotec业绩会实录，以下是财务业绩回顾摘要： ## 1. 财务业绩 **营收表现：** - 前9个月集团总收入为5.351亿欧元，同比下降7% - D&PD（药物发现与临床前开发）业务收入3.919亿欧元，同比下降12% - JEB（Just-Evotec Biologics）生物制药业务收入1.432亿欧元，同比增长11% - 非Sandoz和非DoD客户业务增长105%，Sandoz业务实现低个位数增长 **盈利能力：** - 调整后集团EBITDA为负1,690万欧元，主要受D&PD业务表现不佳和固定成本基数影响 - JEB业务盈利能力
04-09 12:03
Earnings Scheduled For April 8, 2026
Companies Reporting Before The Bell • Beasley Broadcast Group (NASDAQ:BBGI) is ...
04-08 19:11
Evotec Sees FY2026 Sales $814.906M-$908.038M vs $957.470M Est
Evotec (NASDAQ:EVO) sees FY2026 sales of $814.906 million-$908.038 million vs $957.470 million analyst estimate.
04-08 18:30
Evotec Q4 EPS $0.05 Beats $0.02 Estimate, Sales $294.879M Beat $253.350M Estimate
Evotec (NASDAQ:EVO) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $0.02 by 150 percent. This is a 141.67 percent increase over losses of $(0.12) per share from the same
04-08 18:29
Gilead Acquisition Spree Continues With $3 Billion Tubulis Deal
Gilead shares dip after $3.15 billion Tubulis deal adds ADC asset, as multiple acquisitions reshape oncology and autoimmune pipeline outlook.
04-08 00:06
公司簡介
公司名稱
|
Evotec SE
|
行業分類
|
Miscellaneous Commercial Services
|
業務描述
|
Evotec SE is a life science company, which engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the Shared R&D and Justa€“Evotec Biologics segments. The Shared R&D segment includes drug discovery and development services and solutions. The Justa€“Evotec Biologics segment provides services related to designing, discovering, developing, and manufacturing of modern biotherapeutics. The company was founded by Manfred Eigen, Karsten Henco, Ulrich Aldag, Freimut Leidenberger, Heinrich Maria Schulte, Rudolf Rigler, Charles Weissmann, and Nobel Laureate on December 8, 1993 and is headquartered in Hamburg, Germany.
|
Earnings Scheduled For May 6, 2026
Companies Reporting Before The Bell • Deluxe (NYSE:DLX) is expected to report q...
05-07 05:03
Evotec Raises FY2026 Sales Guidance from $814.906M-$908.038M to $819.700M-$913.380M vs $870.860M Est
Evotec (NASDAQ:EVO) raises FY2026 sales outlook from $814.906 million-$908.038 million to $819.700 million-$913.380 million vs $870.860 million estimate.
05-06 15:32
Evotec Q1 EPS $(0.40) Misses $0.08 Estimate, Sales $183.430M Miss $197.190M Estimate
Evotec (NASDAQ:EVO) reported quarterly losses of $(0.40) per share which missed the analyst consensus estimate of $0.08 by 600 percent. This is a 344.44 percent decrease over losses of $(0.10) per share from the same
05-06 15:30
Evotec Nominates Preclinical Development Candidate From Almirall Collaboration Targeting Immune-Mediated Inflammatory Skin Diseases
Joint Evotec-Almirall team advances small molecule program to preclinical development significantly outperforming standard industry timelinesCollaboration leverages Evotec's end-to-end integrated AI/ML-driven R&D
05-04 13:54
Boyd Gaming Posts Downbeat Q1 Results, Joins Coursera, Evotec And Other Big Stocks Moving Lower In Friday's Pre-Market Session
U.S. stock futures mixed, Dow down 100 points. Boyd Gaming Corp shares drop 6.1% after worse-than-expected Q1 results and $500M buyback plan.
04-24 20:03
电话会总结 ｜ Evotec(EVO)2025财年Q3业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Evotec业绩会实录，以下是财务业绩回顾摘要： ## 1. 财务业绩 **营收表现：** - 前9个月集团总收入为5.351亿欧元，同比下降7% - D&PD（药物发现与临床前开发）业务收入3.919亿欧元，同比下降12% - JEB（Just-Evotec Biologics）生物制药业务收入1.432亿欧元，同比增长11% - 非Sandoz和非DoD客户业务增长105%，Sandoz业务实现低个位数增长 **盈利能力：** - 调整后集团EBITDA为负1,690万欧元，主要受D&PD业务表现不佳和固定成本基数影响 - JEB业务盈利能力
04-09 12:03
Earnings Scheduled For April 8, 2026
Companies Reporting Before The Bell • Beasley Broadcast Group (NASDAQ:BBGI) is ...
04-08 19:11
Evotec Sees FY2026 Sales $814.906M-$908.038M vs $957.470M Est
Evotec (NASDAQ:EVO) sees FY2026 sales of $814.906 million-$908.038 million vs $957.470 million analyst estimate.
04-08 18:30
Evotec Q4 EPS $0.05 Beats $0.02 Estimate, Sales $294.879M Beat $253.350M Estimate
Evotec (NASDAQ:EVO) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $0.02 by 150 percent. This is a 141.67 percent increase over losses of $(0.12) per share from the same
04-08 18:29
Gilead Acquisition Spree Continues With $3 Billion Tubulis Deal
Gilead shares dip after $3.15 billion Tubulis deal adds ADC asset, as multiple acquisitions reshape oncology and autoimmune pipeline outlook.
04-08 00:06
派息除權日
|
每股總股息
| 派息日期 |
2019-01-11
|
0.07
|
2019-01-22
|
2018-12-12
|
0.05
|
2018-12-20
|
2018-11-08
|
0.05
|
2018-11-19
|
2018-10-10
|
0.05
|
2018-10-18
|
2018-09-13
|
0.05
|
2018-09-21
|
2018-08-10
|
0.05
|
2018-08-20
|
2018-07-11
|
0.05
|
2018-07-19
|
2018-06-08
|
0.05
|
2018-06-18
|
2018-05-10
|
0.05
|
2018-05-18
|
2018-04-11
|
0.05
|
2018-04-19
|
2018-03-09
|
0.05
|
2018-03-19
|
2018-02-09
|
0.05
|
2018-02-20
|
2018-01-11
|
0.05
|
2018-01-19
|
2017-12-08
|
0.05
|
2017-12-18
|
2017-11-10
|
0.05
|
2017-11-20
|
2017-10-11
|
0.05
|
2017-10-19
|
2017-09-08
|
0.05
|
2017-09-18
|
2017-08-09
|
0.05
|
2017-08-18
|
2017-07-11
|
0.05
|
2017-07-20
|
2017-06-08
|
0.05
|
2017-06-19
|
2017-05-09
|
0.05
|
2017-05-18
|
2017-04-11
|
0.05
|
2017-04-20
|
2017-03-09
|
0.05
|
2017-03-20
|
2017-02-09
|
0.05
|
2017-02-21
|
2017-01-11
|
0.05
|
2017-01-20
|
2016-12-08
|
0.05
|
2016-12-19
|
2016-11-09
|
0.05
|
2016-11-21
|
2016-10-11
|
0.05
|
2016-10-20
|
2016-09-08
|
0.05
|
2016-09-19
|
2016-08-09
|
0.05
|
2016-08-18
|
2016-07-07
|
0.06
|
2016-07-18
|
2016-06-09
|
0.06
|
2016-06-20
|
2016-05-10
|
0.06
|
2016-05-19
|
2016-04-07
|
0.06
|
2016-04-18
|
2016-03-09
|
0.06
|
2016-03-18
|
2016-02-09
|
0.06
|
2016-02-18
|
2016-01-12
|
0.06
|
2016-01-21
|
2015-12-09
|
0.06
|
2015-12-18
|
2015-11-10
|
0.06
|
2015-11-20
|
2015-10-08
|
0.06
|
2015-10-20
|
2015-09-09
|
0.06
|
2015-09-18
|
2015-08-11
|
0.06
|
2015-08-20
|
2015-07-09
|
0.06
|
2015-07-20
|
2015-06-09
|
0.06
|
2015-06-18
|
2015-05-07
|
0.06
|
2015-05-18
|
2015-04-09
|
0.06
|
2015-04-20
|
2015-03-10
|
0.06
|
2015-03-19
|
2015-02-10
|
0.06
|
2015-02-19
|
2015-01-08
|
0.06
|
2015-01-20
|
2014-12-09
|
0.06
|
2014-12-18
|
2014-11-10
|
0.06
|
2014-11-20
|
2014-10-08
|
0.06
|
2014-10-20
|
2014-09-10
|
0.06
|
2014-09-19
|
2014-08-07
|
0.06
|
2014-08-18
|
2014-07-08
|
0.06
|
2014-07-17
|
2014-06-06
|
0.06
|
2014-06-17
|
2014-05-08
|
0.06
|
2014-05-19
|
2014-04-08
|
0.06
|
2014-04-17
|
2014-03-06
|
0.06
|
2014-03-17
|
2014-02-06
|
0.06
|
2014-02-18
|
2014-01-08
|
0.06
|
2014-01-17
|
2013-12-06
|
0.06
|
2013-12-17
|
2013-11-07
|
0.06
|
2013-11-19
|
2013-10-08
|
0.06
|
2013-10-17
|
2013-09-06
|
0.06
|
2013-09-17
|
2013-08-08
|
0.06
|
2013-08-19
|
2013-07-08
|
0.06
|
2013-07-17
|
2013-06-06
|
0.06
|
2013-06-17
|
2013-05-08
|
0.06
|
2013-05-17
|
2013-04-08
|
0.06
|
2013-04-17
|
2013-03-07
|
0.06
|
2013-03-18
|
2013-02-07
|
0.06
|
2013-02-19
|
2013-01-08
|
0.06
|
2013-01-17
|
2012-12-06
|
0.07
|
2012-12-17
|
2012-11-08
|
0.07
|
2012-11-20
|
2012-10-09
|
0.07
|
2012-10-18
|
2012-09-06
|
0.07
|
2012-09-17
|
2012-08-08
|
0.07
|
2012-08-17
|
2012-07-06
|
0.07
|
2012-07-17
|
2012-06-07
|
0.07
|
2012-06-18
|
2012-05-08
|
0.07
|
2012-05-17
|
2012-04-09
|
0.07
|
2012-04-18
|
2012-03-08
|
0.07
|
2012-03-19
|
2012-02-08
|
0.07
|
2012-02-17
|
2012-01-06
|
0.07
|
2012-01-17
|
2011-12-08
|
0.07
|
2011-12-19
|
2011-11-08
|
0.07
|
2011-11-17
|
2011-10-06
|
0.07
|
2011-10-18
|
2011-09-08
|
0.07
|
2011-09-19
|
2011-08-08
|
0.07
|
2011-08-17
|
2011-07-07
|
0.07
|
2011-07-18
|
2011-06-08
|
0.07
|
2011-06-17
|
2011-05-06
|
0.07
|
2011-05-17
|
2011-04-07
|
0.07
|
2011-04-18
|
2011-03-08
|
0.07
|
2011-03-17
|
2011-02-08
|
0.07
|
2011-02-17
|
2011-01-06
|
0.07
|
2011-01-18
|
2010-12-08
|
0.07
|
2010-12-17
|
2010-11-08
|
0.07
|
2010-11-17
|
2010-10-06
|
0.07
|
2010-10-18
|
2010-09-08
|
0.07
|
2010-09-17
|
2010-08-06
|
0.07
|
2010-08-17
|
2010-07-08
|
0.07
|
2010-07-19
|
2010-06-08
|
0.07
|
2010-06-17
|
2010-05-06
|
0.07
|
2010-05-17
|
2010-04-08
|
0.07
|
2010-04-19
|
2010-03-08
|
0.07
|
2010-03-17
|
2010-02-08
|
0.07
|
2010-02-17
|
2010-01-07
|
0.07
|
2010-01-19
|
2009-12-08
|
0.07
|
2009-12-17
|
2009-11-06
|
0.07
|
2009-11-17
|
2009-10-07
|
0.07
|
2009-10-19
|
2009-09-08
|
0.07
|
2009-09-17
|
2009-08-06
|
0.07
|
2009-08-17
|
2009-07-08
|
0.07
|
2009-07-17
|
2009-06-08
|
0.07
|
2009-06-17
|
2009-05-07
|
0.07
|
2009-05-18
|
2009-04-08
|
0.07
|
2009-04-20
|
2009-03-06
|
0.06
|
2009-03-17
|
2009-02-06
|
0.06
|
2009-02-17
|
2009-01-08
|
0.06
|
2009-01-20
|
2008-12-08
|
0.06
|
2008-12-17
|
2008-11-06
|
0.06
|
2008-11-17
|
2008-10-08
|
0.06
|
2008-10-17
|
2008-09-08
|
0.06
|
2008-09-17
|
2008-08-07
|
0.06
|
2008-08-18
|
2008-07-08
|
0.05
|
2008-07-17
|
2008-06-06
|
0.05
|
2008-06-17
|
2008-05-08
|
0.05
|
2008-05-19
|
2008-04-08
|
0.05
|
2008-04-17
|
2008-03-06
|
0.05
|
2008-03-17
|
2008-02-07
|
0.05
|
2008-02-19
|
2008-01-08
|
0.05
|
2008-01-17
|
2007-12-06
|
0.05
|
2007-12-17
|
2007-11-07
|
0.05
|
2007-11-16
|
2007-10-05
|
0.05
|
2007-10-17
|
2007-09-06
|
0.05
|
2007-09-17
|
2007-08-08
|
0.05
|
2007-08-17
|
2007-07-06
|
0.05
|
2007-07-17
|
2007-06-07
|
0.06
|
2007-06-18
|
2007-05-08
|
0.06
|
2007-05-17
|
2007-04-05
|
0.06
|
2007-04-17
|
2007-03-08
|
0.06
|
2007-03-19
|
2007-02-08
|
0.06
|
2007-02-20
|
2007-01-08
|
0.06
|
2007-01-17
|
2006-12-07
|
0.06
|
2006-12-18
|
2006-11-08
|
0.06
|
2006-11-17
|
2006-10-05
|
0.06
|
2006-10-17
|
2006-09-07
|
0.06
|
2006-09-18
|
2006-08-08
|
0.06
|
2006-08-17
|
2006-07-06
|
0.06
|
2006-07-17
|
2006-06-08
|
0.06
|
2006-06-19
|
2006-05-08
|
0.06
|
2006-05-17
|
2006-04-06
|
0.06
|
2006-04-17
|
2006-03-08
|
0.06
|
2006-03-17
|
2006-02-08
|
0.06
|
2006-02-17
|
2006-01-06
|
0.06
|
2006-01-17
|
2005-12-08
|
0.07
|
2005-12-19
|
2005-11-08
|
0.07
|
2005-11-17
|
2005-10-06
|
0.07
|
2005-10-18
|
2005-09-07
|
0.07
|
2005-09-16
|
2005-08-08
|
0.07
|
2005-08-17
|
2005-07-07
|
0.07
|
2005-07-18
|
2005-06-07
|
0.07
|
2005-06-16
|
2005-05-05
|
0.07
|
2005-05-16
|
2005-04-07
|
0.08
|
2005-04-18
|
2005-03-07
|
0.08
|
2005-03-16
|
2005-02-07
|
0.08
|
2005-02-16
|
2005-01-06
|
0.08
|
2005-01-18
|
2004-12-07
|
0.08
|
2004-12-16
|
2004-11-04
|
0.08
|
2004-11-15
|
2004-10-06
|
0.08
|
2004-10-18
|
2004-09-08
|
0.08
|
2004-09-17
|
2004-08-05
|
0.08
|
2004-08-16
|
2004-07-07
|
0.08
|
2004-07-16
|
2004-06-04
|
0.08
|
2004-06-15
|
2004-05-06
|
0.08
|
2004-05-17
|
2004-04-07
|
0.08
|
2004-04-16
|
2004-03-04
|
0.08
|
2004-03-16
|
2004-02-06
|
0.08
|
2004-02-17
|
2004-01-07
|
0.08
|
2004-01-16
|
2003-12-05
|
0.08
|
2003-12-16
|
2003-11-06
|
0.08
|
2003-11-17
|
2003-10-07
|
0.08
|
2003-10-16
|
2003-09-04
|
0.08
|
2003-09-15
|
2003-08-07
|
0.08
|
2003-08-18
|
2003-07-07
|
0.08
|
2003-07-16
|
2003-06-05
|
0.08
|
2003-06-16
|
2003-05-07
|
0.08
|
2003-05-16
|
2003-04-07
|
0.08
|
2003-04-16
|
2003-03-06
|
0.08
|
2003-03-17
|
2003-02-06
|
0.08
|
2003-02-18
|
2003-01-07
|
0.08
|
2003-01-16
|
2002-12-05
|
0.08
|
2002-12-16
|
2002-11-07
|
0.08
|
2002-11-19
|
2002-10-07
|
0.08
|
2002-10-16
|
2002-09-05
|
0.08
|
2002-09-16
|
2002-08-07
|
0.08
|
2002-08-16
|
2002-07-03
|
0.08
|
2002-07-15
|
2002-06-06
|
0.08
|
2002-06-17
|
2002-05-07
|
0.08
|
2002-05-16
|
2002-04-05
|
0.08
|
2002-04-16
|
2002-03-07
|
0.08
|
2002-03-18
|
2002-02-07
|
0.08
|
2002-02-19
|
2002-01-07
|
0.07
|
2002-01-16
|
2001-12-06
|
0.07
|
2001-12-17
|
2001-11-07
|
0.07
|
2001-11-16
|
2001-10-03
|
0.06
|
2001-10-15
|
2001-09-06
|
0.06
|
2001-09-17
|
2001-08-08
|
0.06
|
2001-08-17
|
2001-07-05
|
0.06
|
2001-07-16
|
2001-06-07
|
0.06
|
2001-06-18
|
2001-05-07
|
0.06
|
2001-05-16
|
2001-04-05
|
0.06
|
2001-04-16
|
2001-03-07
|
0.06
|
2001-03-16
|
2001-02-07
|
0.06
|
2001-02-16
|
2001-01-05
|
0.06
|
2001-01-16
|
2000-12-07
|
0.06
|
2000-12-18
|
2000-11-08
|
0.06
|
2000-11-17
|
2000-10-04
|
0.06
|
2000-10-16
|
2000-09-07
|
0.06
|
2000-09-18
|
2000-08-08
|
0.06
|
2000-08-17
|
2000-07-06
|
0.06
|
2000-07-17
|
2000-06-07
|
0.06
|
2000-06-16
|
2000-05-04
|
0.06
|
2000-05-15
|
2000-04-06
|
0.06
|
2000-04-17
|
2000-03-08
|
0.06
|
2000-03-17
|
2000-02-08
|
0.06
|
2000-02-17
|
2000-01-06
|
0.06
|
2000-01-18
|
1999-12-08
|
0.06
|
1999-12-17
|
1999-11-05
|
0.06
|
1999-11-16
|
1999-10-06
|
0.06
|
1999-10-18
|
1999-09-08
|
0.06
|
1999-09-17
|
1999-08-05
|
0.06
|
1999-08-16
|
1999-07-02
|
0.06
|
1999-07-14
|
1999-06-03
|
0.06
|
1999-06-14
|
1999-05-06
|
0.06
|
1999-05-17
|
1999-04-05
|
0.06
|
1999-04-13
|
